Ubs Asset Management Americas Inc Vera Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 82,282 shares of VERA stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,282
Previous 153,098
46.26%
Holding current value
$2.33 Million
Previous $3.61 Million
33.94%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VERA
# of Institutions
194Shares Held
65.9MCall Options Held
128KPut Options Held
172K-
Avoro Capital Advisors LLC New York, NY6.21MShares$176 Million2.46% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.03MShares$114 Million9.86% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.67MShares$104 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.64MShares$103 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$94.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $766M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...